Enfusion Inc
NYSE:ENFN
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.78
10.36
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Enfusion Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | US |
Market Cap | 1.3B USD |
Net Margin |
2%
|
Country | US |
Market Cap | 327.7B USD |
Net Margin |
15%
|
Country | DE |
Market Cap | 263.6B EUR |
Net Margin |
9%
|
Country | US |
Market Cap | 230B USD |
Net Margin |
26%
|
Country | US |
Market Cap | 193.7B USD |
Net Margin |
7%
|
Country | US |
Market Cap | 179.3B USD |
Net Margin |
18%
|
Country | US |
Market Cap | 146.1B USD |
Net Margin |
18%
|
Country | US |
Market Cap | 111.8B USD |
Net Margin |
27%
|
Country | US |
Market Cap | 85.5B USD |
Net Margin |
-87%
|
Country | US |
Market Cap | 86.8B USD |
Net Margin |
25%
|
Country | US |
Market Cap | 85.5B USD |
Net Margin |
24%
|
Enfusion Inc
Glance View
Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. The company is headquartered in Chicago, Illinois. The company went IPO on 2021-10-21. The products and services that comprise its solution are designed to enable investment managers to take investment decisions in real time. The Company’s solution, comprised of mission critical systems integrated with a suite of technology-powered, managed services, serves the full investment lifecycle, drives insights into and control over the business activities of the investment manager and investment operations. Its solution’s end-to-end functionality includes Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System and Enfusion Analytics System. PMS able to comprehensively construct and re-balance investment portfolios, this system generates a real-time investment book of record. PMS module offers portfolio managers, traders, compliance teams and analysts the ability to electronically communicate trade orders.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Enfusion Inc's most recent financial statements, the company has Net Margin of 1.7%.